D22.39 — Melanocytic nevi of other parts of face
D22.39 is a billable, specific ICD-10-CM code for melanocytic nevi of other parts of face. It is valid for submission on a claim.
Other codes that can never be billed with D22.39
These codes carry an Excludes1 note pointing at D22.39. The conflict binds both ways, but ICD-10-CM only writes it down on one side — so you would not find this by reading D22.39 alone.
- D14.0Benign neoplasm of middle ear, nasal cavity and accessory sinuses
Risk adjustment
D22.39 does not map to an HCC and does not risk-adjust under CMS-HCC V28. That is normal — most ICD-10 codes do not. It still needs to be coded correctly; it just will not move a RAF score.
Medicare coverage
D22.39 is named in 29 Medicare coverage policies — 29 listing it as supporting medical necessity. Which of them applies to you depends on your Medicare contractor, and coverage genuinely differs by state.
- A56346Billing and Coding: Removal of Benign and Malignant Skin Lesions
- A56439Billing and Coding: Blepharoplasty
- A56464Billing and Coding: Flow Cytometry
- A56503Billing and Coding: Blepharoplasty, Eyelid Surgery, and Brow Lift
How D22.39 is indexed
Coders do not find codes by browsing the tabular list — they look them up in the alphabetic index, under the word the physician wrote. These are the index entries that lead here, so you can see which chart wordings map to D22.39.
- Papule›fibrous, of nose
- Nevus›skin›ala nasi
- Nevus›skin›brow
- Nevus›skin›cheek(external)
- Nevus›skin›chin
- Nevus›skin›eyebrow
- Nevus›skin›forehead
- Nevus›skin›jaw
- Nevus›skin›nasolabial groove
- Nevus›skin›nose(external)
- Nevus›skin›temple
- Nevus›skin›face›specified NEC
Related codes at this level
Codes that share D22.3. If D22.39 is not quite right, the correct code is usually one of these.
Questions about D22.39
- Is D22.39 a billable ICD-10-CM code?
- Yes. D22.39 is a billable, specific ICD-10-CM code and is valid for submission on a claim.
- Where does D22.39 sit in the tabular list?
- Neoplasms (C00-D49), in the block Benign neoplasms, except benign neuroendocrine tumors (D10-D36).